$CCCS
CCC Intelligent Solutions Holdings Inc.

2024 Q3 Form 10-Q Financial Statement

#000095017024088015 Filed on July 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $238.5M $232.6M
YoY Change 7.84% 9.88%
Cost Of Revenue $55.06M $55.32M
YoY Change -5.11% -5.75%
Gross Profit $183.4M $177.3M
YoY Change 12.44% 15.87%
Gross Profit Margin 76.91% 76.22%
Selling, General & Admin $87.27M $87.59M
YoY Change 2.57% 6.72%
% of Gross Profit 47.58% 49.4%
Research & Development $49.53M $49.25M
YoY Change 13.77% 13.58%
% of Gross Profit 27.0% 27.78%
Depreciation & Amortization $28.47M $29.75M
YoY Change -17.47% -11.0%
% of Gross Profit 15.52% 16.78%
Operating Expenses $154.7M $154.8M
YoY Change 5.58% 7.89%
Operating Profit $28.69M $22.51M
YoY Change 73.12% 135.61%
Interest Expense $16.38M $16.60M
YoY Change 11.93% -360.3%
% of Operating Profit 57.09% 73.74%
Other Income/Expense, Net -$2.587M $1.253M
YoY Change -1521.43% -106.25%
Pretax Income $13.07M $25.75M
YoY Change -167.4% -125.85%
Income Tax $8.900M $4.300M
% Of Pretax Income 68.12% 16.7%
Net Earnings $4.132M $21.45M
YoY Change -119.49% -121.96%
Net Earnings / Revenue 1.73% 9.22%
Basic Earnings Per Share $0.00 $0.03
Diluted Earnings Per Share $0.00 $0.03
COMMON SHARES
Basic Shares Outstanding 623.4M 614.6M
Diluted Shares Outstanding 642.4M 638.4M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $286.3M $237.9M
YoY Change -36.19% -41.05%
Cash & Equivalents $286.3M $237.9M
Short-Term Investments
Other Short-Term Assets $31.86M $26.59M
YoY Change 6.86% -42.34%
Inventory
Prepaid Expenses
Receivables $129.6M $120.9M
Other Receivables $298.0K $4.093M
Total Short-Term Assets $467.8M $408.9M
YoY Change -23.78% -25.87%
LONG-TERM ASSETS
Property, Plant & Equipment $178.5M $176.4M
YoY Change 12.82% -4.75%
Goodwill $1.418B $1.418B
YoY Change 0.0% 0.0%
Intangibles $952.4M $970.5M
YoY Change -8.38% -8.79%
Long-Term Investments $10.23M $10.23M
YoY Change 0.0% 0.0%
Other Assets $35.24M $42.55M
YoY Change -29.34% -42.14%
Total Long-Term Assets $2.647B $2.670B
YoY Change -2.98% -2.93%
TOTAL ASSETS
Total Short-Term Assets $467.8M $408.9M
Total Long-Term Assets $2.647B $2.670B
Total Assets $3.115B $3.079B
YoY Change -6.8% -6.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.80M $20.95M
YoY Change 19.57% 9.8%
Accrued Expenses $57.60M $61.15M
YoY Change -5.58% -0.99%
Deferred Revenue $46.58M $45.99M
YoY Change 11.2% 14.79%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $8.000M $8.000M
YoY Change 0.0% -27.05%
Total Short-Term Liabilities $146.8M $146.6M
YoY Change -1.16% 8.28%
LONG-TERM LIABILITIES
Long-Term Debt $762.6M $764.2M
YoY Change -0.84% -4.47%
Other Long-Term Liabilities $9.316M $10.35M
YoY Change 314.78% -90.55%
Total Long-Term Liabilities $772.0M $774.6M
YoY Change 0.07% -14.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $146.8M $146.6M
Total Long-Term Liabilities $772.0M $774.6M
Total Liabilities $1.154B $1.167B
YoY Change -10.03% -8.68%
SHAREHOLDERS EQUITY
Retained Earnings -$1.101B -$1.106B
YoY Change 33.63% 37.67%
Common Stock $63.00K $62.00K
YoY Change 0.0% -1.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.940B $1.894B
YoY Change
Total Liabilities & Shareholders Equity $3.115B $3.079B
YoY Change -6.8% -6.76%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $4.132M $21.45M
YoY Change -119.49% -121.96%
Depreciation, Depletion And Amortization $28.47M $29.75M
YoY Change -17.47% -11.0%
Cash From Operating Activities $63.23M $51.77M
YoY Change 4.52% -25.56%
INVESTING ACTIVITIES
Capital Expenditures $13.85M $15.56M
YoY Change -1.78% 6.95%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$13.85M -$15.56M
YoY Change -1.78% 6.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.110M 10.52M
YoY Change -7.5% -1.03%
NET CHANGE
Cash From Operating Activities 63.23M 51.77M
Cash From Investing Activities -13.85M -15.56M
Cash From Financing Activities -1.110M 10.52M
Net Change In Cash 48.27M 46.73M
YoY Change 6.8% -28.8%
FREE CASH FLOW
Cash From Operating Activities $63.23M $51.77M
Capital Expenditures $13.85M $15.56M
Free Cash Flow $49.38M $36.21M
YoY Change 6.43% -34.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001818201
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
CCC INTELLIGENT SOLUTIONS HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-39447
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1546280
dei Entity Address Address Line1
EntityAddressAddressLine1
167 N. Green Street
dei Entity Address Address Line2
EntityAddressAddressLine2
9th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60607
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
621-8070
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
CCCS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
623400373
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
237893000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
195572000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4079000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5574000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
120932000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102365000
CY2024Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4093000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1798000
CY2024Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
19427000
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
17900000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
26589000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32364000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
408934000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
349999000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
176391000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29799000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30456000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
970505000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1015046000
CY2024Q2 us-gaap Goodwill
Goodwill
1417724000
CY2023Q4 us-gaap Goodwill
Goodwill
1417724000
CY2024Q2 cccs Deferred Financing Fees Revolver Net Non Current
DeferredFinancingFeesRevolverNetNonCurrent
1365000
CY2023Q4 cccs Deferred Financing Fees Revolver Net Non Current
DeferredFinancingFeesRevolverNetNonCurrent
1672000
CY2024Q2 us-gaap Deferred Costs
DeferredCosts
21666000
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
22302000
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
10228000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10228000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42546000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
43197000
CY2024Q2 us-gaap Assets
Assets
3079158000
CY2023Q4 us-gaap Assets
Assets
3051040000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
20954000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16324000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61149000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
71478000
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
215000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3689000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2024Q2 cccs Long Term Licensing Agreement Net Current
LongTermLicensingAgreementNetCurrent
3157000
CY2023Q4 cccs Long Term Licensing Agreement Net Current
LongTermLicensingAgreementNetCurrent
3061000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7128000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6788000
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
45988000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43567000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
146591000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
152907000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
764249000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
767504000
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
170627000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
195365000
CY2024Q2 cccs Long Term Licensing Agreement Net Non Current
LongTermLicensingAgreementNetNonCurrent
26089000
CY2023Q4 cccs Long Term Licensing Agreement Net Non Current
LongTermLicensingAgreementNetNonCurrent
27692000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48657000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50796000
CY2024Q2 cccs Warrant Liablity
WarrantLiablity
0
CY2023Q4 cccs Warrant Liablity
WarrantLiablity
51501000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10352000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6414000
CY2024Q2 us-gaap Liabilities
Liabilities
1166565000
CY2023Q4 us-gaap Liabilities
Liabilities
1252179000
CY2024Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
18947000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
16584000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
622795101
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
622795101
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
603128781
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603128781
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
62000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
60000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3000367000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2909757000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1105619000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1126467000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1164000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1073000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1893646000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1782277000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3079158000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3051040000
CY2024Q2 us-gaap Revenues
Revenues
232618000
CY2023Q2 us-gaap Revenues
Revenues
211710000
us-gaap Revenues
Revenues
459855000
us-gaap Revenues
Revenues
416630000
CY2024Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
53231000
CY2023Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
52047000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
106038000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
102494000
CY2024Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
2090000
CY2023Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
6646000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
8657000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
13331000
CY2024Q2 cccs Impairment Of Acquired Technologies
ImpairmentOfAcquiredTechnologies
0
CY2023Q2 cccs Impairment Of Acquired Technologies
ImpairmentOfAcquiredTechnologies
431000
cccs Impairment Of Acquired Technologies
ImpairmentOfAcquiredTechnologies
0
cccs Impairment Of Acquired Technologies
ImpairmentOfAcquiredTechnologies
431000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
55321000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
59124000
us-gaap Cost Of Revenue
CostOfRevenue
114695000
us-gaap Cost Of Revenue
CostOfRevenue
116256000
CY2024Q2 us-gaap Gross Profit
GrossProfit
177297000
CY2023Q2 us-gaap Gross Profit
GrossProfit
152586000
us-gaap Gross Profit
GrossProfit
345160000
us-gaap Gross Profit
GrossProfit
300374000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49253000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43363000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
98730000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
84359000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36321000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
35936000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
71907000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
69467000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51268000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46141000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
108329000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
88006000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17942000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18022000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35884000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
36088000
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
77405000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
77405000
CY2024Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
4906000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
4906000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
154784000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
225773000
us-gaap Operating Expenses
OperatingExpenses
314850000
us-gaap Operating Expenses
OperatingExpenses
360231000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
22513000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-73187000
us-gaap Operating Income Loss
OperatingIncomeLoss
30310000
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
77405000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
77405000
CY2024Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
4906000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
4906000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
154784000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
225773000
us-gaap Operating Expenses
OperatingExpenses
314850000
us-gaap Operating Expenses
OperatingExpenses
360231000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
22513000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-73187000
CY2024Q2 us-gaap Interest Expense
InterestExpense
16602000
CY2023Q2 us-gaap Interest Expense
InterestExpense
14014000
us-gaap Interest Expense
InterestExpense
33054000
us-gaap Interest Expense
InterestExpense
27846000
CY2024Q2 us-gaap Interest Income Operating
InterestIncomeOperating
2625000
CY2023Q2 us-gaap Interest Income Operating
InterestIncomeOperating
4023000
us-gaap Interest Income Operating
InterestIncomeOperating
5092000
us-gaap Interest Income Operating
InterestIncomeOperating
7282000
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-15963000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20375000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-14378000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
19180000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1253000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3928000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4191000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1377000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25752000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-99625000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20917000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4307000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2281000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3064000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
21445000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-97344000
us-gaap Net Income Loss
NetIncomeLoss
20848000
us-gaap Net Income Loss
NetIncomeLoss
-95160000
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1221000
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
315000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2363000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
315000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20224000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-97659000
us-gaap Operating Income Loss
OperatingIncomeLoss
-59857000
CY2024Q2 us-gaap Interest Expense
InterestExpense
16602000
CY2023Q2 us-gaap Interest Expense
InterestExpense
14014000
us-gaap Interest Expense
InterestExpense
33054000
us-gaap Interest Expense
InterestExpense
27846000
CY2024Q2 us-gaap Interest Income Operating
InterestIncomeOperating
2625000
CY2023Q2 us-gaap Interest Income Operating
InterestIncomeOperating
4023000
us-gaap Interest Income Operating
InterestIncomeOperating
5092000
us-gaap Interest Income Operating
InterestIncomeOperating
7282000
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-15963000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20375000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-14378000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
19180000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1253000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3928000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4191000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1377000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25752000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-99625000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20917000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-98224000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4307000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2281000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3064000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
21445000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-97344000
us-gaap Net Income Loss
NetIncomeLoss
20848000
us-gaap Net Income Loss
NetIncomeLoss
-95160000
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1221000
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
315000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2363000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
315000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20224000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-97659000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18485000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-95475000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
609997114
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
621235776
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18485000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-95475000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
609997114
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
621235776
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
604138246
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
618740340
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
638367745
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
621235776
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
636990633
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
618740340
CY2024Q2 us-gaap Profit Loss
ProfitLoss
21445000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-97344000
us-gaap Profit Loss
ProfitLoss
20848000
us-gaap Profit Loss
ProfitLoss
-95160000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-285000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-91000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-251000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
21429000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-97629000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
20757000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-95411000
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1221000
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
315000
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2363000
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
315000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20208000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-97944000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18394000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95726000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1782277000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44971000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
8822000
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1833000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-52580000
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1142000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-75000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-597000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1783509000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
604138246
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
618740340
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
638367745
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
621235776
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
636990633
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
618740340
CY2024Q2 us-gaap Profit Loss
ProfitLoss
21445000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-97344000
us-gaap Profit Loss
ProfitLoss
20848000
us-gaap Profit Loss
ProfitLoss
-95160000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-285000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-91000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-251000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
21429000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-97629000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
20757000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-95411000
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1221000
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
315000
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2363000
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
315000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20208000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-97944000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18394000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95726000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1782277000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44971000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
8822000
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1833000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-52580000
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1142000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-75000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-597000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1783509000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40125000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
12824000
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-142000
CY2024Q2 cccs Warrant Redemption
WarrantRedemption
37122000
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1221000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
21445000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1893646000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2045287000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28930000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
8243000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40125000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
12824000
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-142000
CY2024Q2 cccs Warrant Redemption
WarrantRedemption
37122000
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1221000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
21445000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1893646000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2045287000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28930000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
8243000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1326000
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-11449000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
34000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
2184000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35900000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-90000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-285000
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
315000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-97344000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2025006000
us-gaap Profit Loss
ProfitLoss
20848000
us-gaap Profit Loss
ProfitLoss
-95160000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19160000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17966000
cccs Amortization Of Intangible Asset
AmortizationOfIntangibleAsset
44541000
cccs Amortization Of Intangible Asset
AmortizationOfIntangibleAsset
49419000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
82742000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-24738000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23791000
us-gaap Share Based Compensation
ShareBasedCompensation
85096000
us-gaap Share Based Compensation
ShareBasedCompensation
64720000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
927000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
851000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
125000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
111000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-134000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1009000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-14378000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
19180000
cccs Noncash Lease Expense
NoncashLeaseExpense
0
cccs Noncash Lease Expense
NoncashLeaseExpense
1232000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-302000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-68000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-115000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1326000
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-11449000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
34000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
2184000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2074555000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35900000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
12585000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-90000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-285000
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
315000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-97344000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2025006000
us-gaap Profit Loss
ProfitLoss
20848000
us-gaap Profit Loss
ProfitLoss
-95160000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19160000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17966000
cccs Amortization Of Intangible Asset
AmortizationOfIntangibleAsset
44541000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-24738000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23791000
us-gaap Share Based Compensation
ShareBasedCompensation
85096000
us-gaap Share Based Compensation
ShareBasedCompensation
64720000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
927000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
851000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
125000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
111000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-134000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1009000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-14378000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
19180000
cccs Noncash Lease Expense
NoncashLeaseExpense
0
cccs Noncash Lease Expense
NoncashLeaseExpense
1232000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-302000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-68000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-115000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18553000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2322000
cccs Increase Decrease In Deferred Costs Current
IncreaseDecreaseInDeferredCostsCurrent
1527000
cccs Increase Decrease In Deferred Costs Current
IncreaseDecreaseInDeferredCostsCurrent
315000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-5860000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-7116000
cccs Increase Decrease In Deferred Costs Non Current
IncreaseDecreaseInDeferredCostsNonCurrent
-636000
cccs Increase Decrease In Deferred Costs Non Current
IncreaseDecreaseInDeferredCostsNonCurrent
-681000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-391000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
5267000
cccs Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-1152000
cccs Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
5000
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-5769000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18553000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2322000
cccs Increase Decrease In Deferred Costs Current
IncreaseDecreaseInDeferredCostsCurrent
1527000
cccs Increase Decrease In Deferred Costs Current
IncreaseDecreaseInDeferredCostsCurrent
315000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-5860000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-7116000
cccs Increase Decrease In Deferred Costs Non Current
IncreaseDecreaseInDeferredCostsNonCurrent
-681000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-391000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
5267000
cccs Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-1152000
cccs Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
5000
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-5769000
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
772000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4633000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8534000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12739000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14975000
cccs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2236000
cccs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-249000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2437000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4825000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
639000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-115000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
107009000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
102632000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31224000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29084000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31224000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29084000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21561000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20827000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1833000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1326000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
52722000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11539000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-33328000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-136000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-373000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
42321000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
79789000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195572000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
323788000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237893000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
403577000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7218000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
550000
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
772000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4633000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8534000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12739000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14975000
cccs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2236000
cccs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-249000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2437000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4825000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
639000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-115000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
107009000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
102632000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31224000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29084000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31224000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29084000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21561000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20827000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1833000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1326000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
52722000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11539000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-33328000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6614000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-136000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-373000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
42321000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
79789000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195572000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
323788000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237893000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
403577000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7218000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
550000
us-gaap Paid In Kind Interest
PaidInKindInterest
31739000
us-gaap Paid In Kind Interest
PaidInKindInterest
26946000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
30567000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19954000
us-gaap Paid In Kind Interest
PaidInKindInterest
31739000
us-gaap Paid In Kind Interest
PaidInKindInterest
26946000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
30567000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19954000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">—The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">preparation of the condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts, and the disclosures of contingent amounts, in the Company’s condensed consolidated financial statements and the accompanying notes. Although the Company regularly assesses these estimates, actual</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">results </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">could differ from those estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results could differ from management’s estimates if past experience or other assumptions are not substantially accurate. Significant estimates in these condensed consolidated financial statements include the estimation of contract transaction prices, the determination of the amortization period for contract assets, the valuation of goodwill and intangible assets, the valuation of the warrant liabilities, and the estimates and assumptions associated with stock incentive plans.</span>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">—</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications of prior period amounts have been made to conform to the current period presentation. For the three and six months ended June 30, 2024, changes in the fair value of the Company's interest rate cap agreements are recognized within other income (expense)—net in the condensed consolidated statements of operations and comprehensive income (loss). Corresponding amounts recognized during the three and six months ended June 30, 2023, were previously classified as a change in fair value of derivative instruments and have been reclassified to conform to the current period presentation. The amounts reclassified had no impact on net income (loss)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">—The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">preparation of the condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts, and the disclosures of contingent amounts, in the Company’s condensed consolidated financial statements and the accompanying notes. Although the Company regularly assesses these estimates, actual</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">results </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">could differ from those estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results could differ from management’s estimates if past experience or other assumptions are not substantially accurate. Significant estimates in these condensed consolidated financial statements include the estimation of contract transaction prices, the determination of the amortization period for contract assets, the valuation of goodwill and intangible assets, the valuation of the warrant liabilities, and the estimates and assumptions associated with stock incentive plans.</span>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">—</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications of prior period amounts have been made to conform to the current period presentation. For the three and six months ended June 30, 2024, changes in the fair value of the Company's interest rate cap agreements are recognized within other income (expense)—net in the condensed consolidated statements of operations and comprehensive income (loss). Corresponding amounts recognized during the three and six months ended June 30, 2023, were previously classified as a change in fair value of derivative instruments and have been reclassified to conform to the current period presentation. The amounts reclassified had no impact on net income (loss)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p>
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
232618000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
211710000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
459855000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
416630000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1600000000
CY2024Q2 cccs Revenue Remaining Performance Obligation Revenue To Be Recognized Year One
RevenueRemainingPerformanceObligationRevenueToBeRecognizedYearOne
642000000
CY2024Q2 cccs Revenue Remaining Performance Obligation Revenue To Be Recognized Thereafter
RevenueRemainingPerformanceObligationRevenueToBeRecognizedThereafter
958000000
CY2024Q2 cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
41300000
CY2023Q2 cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
39100000
cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
39900000
cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
34600000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
120932000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102365000
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
19427000
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
17900000
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
21666000
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
22302000
CY2024Q2 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
16138000
CY2023Q4 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
15198000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45988000
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
232618000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
211710000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
459855000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
416630000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1600000000
CY2024Q2 cccs Revenue Remaining Performance Obligation Revenue To Be Recognized Year One
RevenueRemainingPerformanceObligationRevenueToBeRecognizedYearOne
642000000
CY2024Q2 cccs Revenue Remaining Performance Obligation Revenue To Be Recognized Thereafter
RevenueRemainingPerformanceObligationRevenueToBeRecognizedThereafter
958000000
CY2024Q2 cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
41300000
CY2023Q2 cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
39100000
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
19427000
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
17900000
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
21666000
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
22302000
CY2024Q2 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
16138000
CY2023Q4 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
15198000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45988000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43567000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2113000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1373000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
47560000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41422000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44940000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
36479000
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-117797000
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-111533000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-233209000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-214718000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43567000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2113000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1373000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
47560000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41422000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44940000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
36479000
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-117797000
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-111533000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-233209000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-214718000
CY2024Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
118338000
CY2023Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
111314000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
236370000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
219442000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48101000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41203000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48101000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41203000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45988000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40064000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45988000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40064000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2113000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1139000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2113000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1139000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48101000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41203000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48101000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41203000
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
40153000
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
37551000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
40202000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36717000
CY2024Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-5322000
CY2023Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-4637000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-10571000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-9423000
CY2024Q2 cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
6262000
CY2023Q2 cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
3437000
cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
11462000
cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
9057000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
41093000
CY2024Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
118338000
CY2023Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
111314000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
236370000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
219442000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48101000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41203000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48101000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41203000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45988000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40064000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45988000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40064000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2113000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1139000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2113000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1139000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48101000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41203000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48101000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41203000
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
40153000
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
37551000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
40202000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36717000
CY2024Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-5322000
CY2023Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-4637000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-10571000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-9423000
CY2024Q2 cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
6262000
CY2023Q2 cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
3437000
cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
11462000
cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
9057000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
41093000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36351000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
41093000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36351000
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
19427000
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
16871000
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
19427000
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
16871000
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
21666000
CY2023Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
19480000
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
21666000
CY2023Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
19480000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
41093000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36351000
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
19427000
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
16871000
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
19427000
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
16871000
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
21666000
CY2023Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
19480000
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
21666000
CY2023Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
19480000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
41093000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36351000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
41093000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36351000
cccs Discount Rate Based On Cost Of Debt
DiscountRateBasedOnCostOfDebt
0.10
CY2024Q2 cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
CY2023Q2 cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4300000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
41093000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36351000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
41093000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36351000
cccs Discount Rate Based On Cost Of Debt
DiscountRateBasedOnCostOfDebt
0.10
CY2024Q2 cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
CY2023Q2 cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4300000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3100000
CY2024Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
30000000
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
19800000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3100000
CY2024Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
30000000
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
19800000
us-gaap Income Taxes Paid
IncomeTaxesPaid
30600000
us-gaap Income Taxes Paid
IncomeTaxesPaid
20000000
CY2024Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
125011000
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
107939000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4079000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5574000
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
120932000
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
102365000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4792000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6866000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5574000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5339000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
794000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
2017000
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
1759000
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
5153000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1507000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3009000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3254000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4618000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4079000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5874000
CY2024Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
125011000
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
107939000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4079000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5574000
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
120932000
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
102365000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4792000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6866000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5574000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5339000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
794000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
2017000
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
1759000
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
5153000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1507000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3009000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3254000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4618000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4079000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5874000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4079000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5874000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4079000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5874000
CY2024Q2 cccs Prepaid Saas Costs
PrepaidSaasCosts
7445000
CY2023Q4 cccs Prepaid Saas Costs
PrepaidSaasCosts
7833000
CY2024Q2 cccs Prepaid Service Fee
PrepaidServiceFee
6285000
CY2023Q4 cccs Prepaid Service Fee
PrepaidServiceFee
5992000
CY2024Q2 cccs Prepaid Software And Equipment Maintenance
PrepaidSoftwareAndEquipmentMaintenance
3090000
CY2023Q4 cccs Prepaid Software And Equipment Maintenance
PrepaidSoftwareAndEquipmentMaintenance
5547000
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
264000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2289000
CY2024Q2 us-gaap Other Assets
OtherAssets
9505000
CY2023Q4 us-gaap Other Assets
OtherAssets
10703000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26589000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32364000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
314683000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
285418000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
138292000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
125002000
CY2024Q2 cccs Prepaid Saas Costs
PrepaidSaasCosts
7445000
CY2023Q4 cccs Prepaid Saas Costs
PrepaidSaasCosts
7833000
CY2024Q2 cccs Prepaid Service Fee
PrepaidServiceFee
6285000
CY2023Q4 cccs Prepaid Service Fee
PrepaidServiceFee
5992000
CY2024Q2 cccs Prepaid Software And Equipment Maintenance
PrepaidSoftwareAndEquipmentMaintenance
3090000
CY2023Q4 cccs Prepaid Software And Equipment Maintenance
PrepaidSoftwareAndEquipmentMaintenance
5547000
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
264000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2289000
CY2024Q2 us-gaap Other Assets
OtherAssets
9505000
CY2023Q4 us-gaap Other Assets
OtherAssets
10703000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26589000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32364000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
314683000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
285418000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
138292000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
125002000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
176391000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
176391000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2024Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
9700000
CY2023Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
8800000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
19200000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
18000000
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1299000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1486000
us-gaap Operating Lease Cost
OperatingLeaseCost
2707000
us-gaap Operating Lease Cost
OperatingLeaseCost
2989000
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1093000
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1017000
us-gaap Variable Lease Cost
VariableLeaseCost
2194000
us-gaap Variable Lease Cost
VariableLeaseCost
1901000
CY2024Q2 us-gaap Lease Cost
LeaseCost
2392000
CY2023Q2 us-gaap Lease Cost
LeaseCost
2503000
us-gaap Lease Cost
LeaseCost
4901000
us-gaap Lease Cost
LeaseCost
4890000
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2000000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1400000
us-gaap Operating Lease Payments
OperatingLeasePayments
3800000
us-gaap Operating Lease Payments
OperatingLeasePayments
2000000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
700000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q2 us-gaap Goodwill Gross
GoodwillGross
1520926000
CY2024Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
103202000
CY2024Q2 us-gaap Goodwill
Goodwill
1417724000
CY2024Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
9700000
CY2023Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
8800000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
19200000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
18000000
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1299000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1486000
us-gaap Operating Lease Cost
OperatingLeaseCost
2707000
us-gaap Operating Lease Cost
OperatingLeaseCost
2989000
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1093000
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1017000
us-gaap Variable Lease Cost
VariableLeaseCost
2194000
us-gaap Variable Lease Cost
VariableLeaseCost
1901000
CY2024Q2 us-gaap Lease Cost
LeaseCost
2392000
CY2023Q2 us-gaap Lease Cost
LeaseCost
2503000
us-gaap Lease Cost
LeaseCost
4901000
us-gaap Lease Cost
LeaseCost
4890000
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2000000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1400000
us-gaap Operating Lease Payments
OperatingLeasePayments
3800000
us-gaap Operating Lease Payments
OperatingLeasePayments
2000000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
700000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q2 us-gaap Goodwill Gross
GoodwillGross
1520926000
CY2024Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
103202000
CY2024Q2 us-gaap Goodwill
Goodwill
1417724000
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
1520926000
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
103202000
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
1520926000
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
103202000
CY2023Q4 us-gaap Goodwill
Goodwill
1417724000
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
77400000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
25800000
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1476470000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-696435000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
780035000
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1666940000
CY2024Q2 cccs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
-696435000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
970505000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1476470000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-651894000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
824576000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1666940000
CY2023Q4 cccs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
-651894000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1015046000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
36227000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
72454000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
72454000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
72454000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
72454000
CY2024Q2 cccs Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
453992000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
780035000
CY2023Q4 us-gaap Goodwill
Goodwill
1417724000
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
77400000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
25800000
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1476470000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-696435000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
780035000
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1666940000
CY2024Q2 cccs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
-696435000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
970505000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1476470000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-651894000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
824576000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1666940000
CY2023Q4 cccs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
-651894000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1015046000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
36227000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
72454000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
72454000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
72454000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
72454000
CY2024Q2 cccs Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
453992000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
780035000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
34626000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54593000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7542000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2183000
CY2024Q2 cccs Software License Agreement Current
SoftwareLicenseAgreementCurrent
4654000
CY2023Q4 cccs Software License Agreement Current
SoftwareLicenseAgreementCurrent
2233000
CY2024Q2 cccs Accrued Royalties And Licenses Current
AccruedRoyaltiesAndLicensesCurrent
4465000
CY2023Q4 cccs Accrued Royalties And Licenses Current
AccruedRoyaltiesAndLicensesCurrent
4381000
CY2024Q2 cccs Accrued Sales Tax Current
AccruedSalesTaxCurrent
3199000
CY2023Q4 cccs Accrued Sales Tax Current
AccruedSalesTaxCurrent
2968000
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2736000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2572000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3927000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2548000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61149000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
71478000
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
3937000
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
3937000
CY2024Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2113000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1373000
CY2024Q2 cccs Software License Agreement Noncurrent
SoftwareLicenseAgreementNoncurrent
4302000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
34626000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54593000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7542000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2183000
CY2024Q2 cccs Software License Agreement Current
SoftwareLicenseAgreementCurrent
4654000
CY2023Q4 cccs Software License Agreement Current
SoftwareLicenseAgreementCurrent
2233000
CY2024Q2 cccs Accrued Royalties And Licenses Current
AccruedRoyaltiesAndLicensesCurrent
4465000
CY2023Q4 cccs Accrued Royalties And Licenses Current
AccruedRoyaltiesAndLicensesCurrent
4381000
CY2024Q2 cccs Accrued Sales Tax Current
AccruedSalesTaxCurrent
3199000
CY2023Q4 cccs Accrued Sales Tax Current
AccruedSalesTaxCurrent
2968000
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2736000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2572000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3927000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2548000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61149000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
71478000
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
3937000
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
3937000
CY2024Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2113000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1373000
CY2024Q2 cccs Software License Agreement Noncurrent
SoftwareLicenseAgreementNoncurrent
4302000
CY2023Q4 cccs Software License Agreement Noncurrent
SoftwareLicenseAgreementNoncurrent
1004000
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
100000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10352000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6414000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
764249000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
767504000
CY2020Q1 cccs Percentage Of Compound Interest Per Annum On The Preferred Share Issue Price
PercentageOfCompoundInterestPerAnnumOnThePreferredShareIssuePrice
0.10
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
17726000
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
16584000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1221000
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
315000
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2363000
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
315000
CY2024Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
18947000
CY2023Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14494000
CY2024Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
18947000
CY2023Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14494000
CY2023Q4 cccs Software License Agreement Noncurrent
SoftwareLicenseAgreementNoncurrent
1004000
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
100000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10352000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6414000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
764249000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
767504000
CY2020Q1 cccs Percentage Of Compound Interest Per Annum On The Preferred Share Issue Price
PercentageOfCompoundInterestPerAnnumOnThePreferredShareIssuePrice
0.10
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
17726000
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
16584000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1221000
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
315000
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2363000
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
315000
CY2024Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
18947000
CY2023Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14494000
CY2023Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14494000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
cccs Shares Authorized Total
SharesAuthorizedTotal
5000000000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
622795101
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
622795101
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603128781
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
603128781
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
141450000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
(i) the extension of the performance period by one year, (ii) a change to the performance criteria, (iii) a change to the number of units to be issued depending on performance and (iv) for certain grants, imposing a maximum number of units to be issued depending on performance equal to 100% of the target.The modification to the performance-based RSUs subject to a market condition resulted in incremental stock-based compensation expense of $67.0 million, which is being recognized ratably over the modified performance periods.
CY2023 cccs Percentage Of Number Of Units To Be Issued Depending On Performance
PercentageOfNumberOfUnitsToBeIssuedDependingOnPerformance
1
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
35788469
CY2023Q4 cccs Share Based Compensation By Share Based Payment Award Non Vested Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationByShareBasedPaymentAwardNonVestedOptionsOutstandingWeightedAverageExercisePrice
296
CY2023 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingWeightedAverageRemainingContractualTerm
P4Y
CY2023Q4 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingAggregateIntrinsicValue
301563000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7865250
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
10217
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.49
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
27913002
CY2024Q2 cccs Share Based Compensation By Share Based Payment Award Non Vested Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationByShareBasedPaymentAwardNonVestedOptionsOutstandingWeightedAverageExercisePrice
3.02
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
cccs Shares Authorized Total
SharesAuthorizedTotal
5000000000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
622795101
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
622795101
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603128781
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
603128781
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
141450000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
(i) the extension of the performance period by one year, (ii) a change to the performance criteria, (iii) a change to the number of units to be issued depending on performance and (iv) for certain grants, imposing a maximum number of units to be issued depending on performance equal to 100% of the target.The modification to the performance-based RSUs subject to a market condition resulted in incremental stock-based compensation expense of $67.0 million, which is being recognized ratably over the modified performance periods.
CY2023 cccs Percentage Of Number Of Units To Be Issued Depending On Performance
PercentageOfNumberOfUnitsToBeIssuedDependingOnPerformance
1
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
35788469
CY2023Q4 cccs Share Based Compensation By Share Based Payment Award Non Vested Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationByShareBasedPaymentAwardNonVestedOptionsOutstandingWeightedAverageExercisePrice
296
CY2023 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingWeightedAverageRemainingContractualTerm
P4Y
CY2023Q4 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingAggregateIntrinsicValue
301563000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7865250
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
10217
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.49
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
27913002
CY2024Q2 cccs Share Based Compensation By Share Based Payment Award Non Vested Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationByShareBasedPaymentAwardNonVestedOptionsOutstandingWeightedAverageExercisePrice
3.02
cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingWeightedAverageRemainingContractualTerm
P3Y7M6D
CY2024Q2 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingAggregateIntrinsicValue
225727000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
26936712
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.9
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
221157000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
27878594
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y7M6D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
225584000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1900000
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
70200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D
cccs Private Warrants Valued On The Redemption Date Using The Black Scholes Option Pricing Model Tabletextblock
PrivateWarrantsValuedOnTheRedemptionDateUsingTheBlackScholesOptionPricingModelTabletextblock
<span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Private Warrants were valued on the Redemption Date using the Black-Scholes option pricing model with the following assumptions:</span> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:95.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:80.04%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:16.36%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected term (in years)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected volatility</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected dividend yield</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.80</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table>
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16000000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20400000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-14400000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
19200000
CY2023Q4 cccs Warrant Liablity
WarrantLiablity
51500000
CY2024Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
26200000
CY2024Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
27900000
CY2024Q2 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
48400000
cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingWeightedAverageRemainingContractualTerm
P3Y7M6D
CY2024Q2 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingAggregateIntrinsicValue
225727000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
26936712
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.9
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
221157000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
27878594
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y7M6D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
225584000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1900000
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
70200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D
cccs Private Warrants Valued On The Redemption Date Using The Black Scholes Option Pricing Model Tabletextblock
PrivateWarrantsValuedOnTheRedemptionDateUsingTheBlackScholesOptionPricingModelTabletextblock
<span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Private Warrants were valued on the Redemption Date using the Black-Scholes option pricing model with the following assumptions:</span> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:95.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:80.04%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:16.36%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected term (in years)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected volatility</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected dividend yield</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.80</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table>
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16000000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20400000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-14400000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
19200000
CY2023Q4 cccs Warrant Liablity
WarrantLiablity
51500000
CY2024Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
26200000
CY2024Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
27900000
CY2024Q2 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
48400000
CY2024Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-852000
CY2023Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
3613000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-134000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1009000
CY2024Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2008000
CY2023Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
4039000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
97000
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
315000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
286000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
368000
CY2024Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-852000
CY2023Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
3613000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-134000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1009000
CY2024Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2008000
CY2023Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
4039000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
97000
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
315000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
286000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
368000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1253000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3928000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4191000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1377000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
21445000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-97344000
us-gaap Net Income Loss
NetIncomeLoss
20848000
us-gaap Net Income Loss
NetIncomeLoss
-95160000
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1221000
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
315000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2363000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
315000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20224000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-97659000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18485000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-95475000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
609997114
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
621235776
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
604138246
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
618740340
CY2024Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
28370631000
CY2023Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
32852387000
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
638367745
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
621235776
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
636990633
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
618740340
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
52267
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30191730
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4794260
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30147441
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1253000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3928000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4191000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1377000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
21445000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-97344000
us-gaap Net Income Loss
NetIncomeLoss
20848000
us-gaap Net Income Loss
NetIncomeLoss
-95160000
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1221000
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
315000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2363000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
315000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20224000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-97659000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18485000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-95475000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
609997114
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
621235776
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
604138246
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
618740340
CY2024Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
28370631000
CY2023Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
638367745
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
621235776
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
636990633
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
52267
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30191730
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4794260
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30147441
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q2 us-gaap Revenues
Revenues
232618000
CY2023Q2 us-gaap Revenues
Revenues
211710000
us-gaap Revenues
Revenues
459855000
us-gaap Revenues
Revenues
416630000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
176391000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2024Q2 ecd Trd Arr Ind Name
TrdArrIndName
Eileen Schloss
CY2024Q2 ecd Trd Arr Ind Title
TrdArrIndTitle
Director of the Company
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2024Q2 ecd Trd Arr Adoption Date
TrdArrAdoptionDate
May 3, 2024
CY2024Q2 ecd Trd Arr Securities Agg Avail Amt
TrdArrSecuritiesAggAvailAmt
99925
CY2024Q2 us-gaap Revenues
Revenues
232618000
CY2023Q2 us-gaap Revenues
Revenues
211710000
us-gaap Revenues
Revenues
459855000
us-gaap Revenues
Revenues
416630000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
176391000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2024Q2 ecd Trd Arr Ind Name
TrdArrIndName
Eileen Schloss
CY2024Q2 ecd Trd Arr Ind Title
TrdArrIndTitle
Director of the Company
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2024Q2 ecd Trd Arr Adoption Date
TrdArrAdoptionDate
May 3, 2024
CY2024Q2 ecd Trd Arr Securities Agg Avail Amt
TrdArrSecuritiesAggAvailAmt
99925

Files In Submission

Name View Source Status
0000950170-24-088015-index-headers.html Edgar Link pending
0000950170-24-088015-index.html Edgar Link pending
0000950170-24-088015.txt Edgar Link pending
0000950170-24-088015-xbrl.zip Edgar Link pending
cccs-20240630.htm Edgar Link pending
cccs-20240630.xsd Edgar Link pending
cccs-ex31_1.htm Edgar Link pending
cccs-ex31_2.htm Edgar Link pending
cccs-ex32_1.htm Edgar Link pending
cccs-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cccs-20240630_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending